IDH1 and cancer: The putative targets of 1p/19q codeletion, tumor suppressor genes FUBP1 and CIC, along with TERT promoter and IDH1/2 variants, generate a unique constellation of genetic aberrations which distinguish these tumors not only from other gliomas, but from most other human cancers [10–12].